HIV research performed by Jan Terje Andersen's group presented in Aftenposten

The major national Norwegian newspaper Aftenposten has recently presented the research of Jan Terje Andersen's "Laboratory of Adaptive Immunity and Homeostasis" group in a feature article entitled "Antistoffer may lead to new HIV medicine.
The goal is a brand new long-acting, preventive HIV medicine that is adapted to the most vulnerable among us.
Links:
The article in Aftenposten (in Norwegian):
Antistoffer kan gi ny hiv-medisin
Home page of Jan Terje Andersen's group:
The Laboratory of Adaptive Immunity and Homeostasis
Previous news articles about Andersen from www.ous-research.no:
Jan Terje Andersen head of hiv research program receiving 19 mill NOK
Jan Terje Andersen receives a grant of 8.5 million NOK from NANO2021
Oslo University Hospital honouring excellent research
Fridtjof Nansen awards for excellent research to Anne-Lise Børresen-Dale and Jan Terje Andersen